Table 3 Diurnal salivary cortisol concentration during intervention and follow up period

0

14.3(5.8-28.9)

4.9(2.4-23.3)

2.8(1.6-7.1)

14.0(6.9-35.0)

18.5(3.9-28.5)

6.2(3.7-10.0)

2.8(1.1-8.5)

17.0(7.6-28.6)

ns

3

13.4(6.2-26.7)

6.3(3.1-10.1)

2.6(1.2-6.1)

14.1(6.7-29.5)

15.9(8.8-18.8)

3.9(3.0-10.5)

1.9(1.4-7.8)

12.4(8.1-34.0)

ns

8

12.1(6.6-37.3)

4.9(2.9-14.3)

2.5(1.5-4.8)

14.0(7.6-34.9)

11.6(6.9-28.0)

5.1(2.7-10.3)

2.6(1.1-7.6)

12.6(5.6-28.2)

ns

21

12.2(5.6-25.4)

6.2(3.5-18.4)

3.1(1.2-7.9)

13.2(6.5-26.9)

12.5(6.4-19.5)

6.0(3.5-8.0)

2.6(1.4-9.8)

14.3(6.2-42.0)

ns

34

13.2(6.3-35.9)

7.3(3.5-16.8)

2.6(1.4-11.3)

15.1(5.7-32.0)

14.5(6.4-30.0)

6.4(3.2-11.0)

3.5(1.3-9.4)

13.4(7.0-40.9)

ns

p-values ²

ns

ns

ns

ns

ns

ns

ns

ns